VIDEO: Specialist shares positive experience with Eylea HD
Click Here to Manage Email Alerts
BARCELONA, Spain — In this Healio Video Perspective from the Euretina congress, Michael W. Stewart, MD, shares his experience with Eylea HD in neovascular age-related macular degeneration and diabetic macular edema.
Stewart was an early adopter of Eylea HD (aflibercept 8 mg, Regeneron) and initially used the drug on patients who were difficult to treat and needed to be switched. The positive results he observed in this patient group led him to use Eylea HD in treatment-naive patients with AMD in whom the drug performed “magnificently,” allowing for extension of the treatment interval even sooner than in the trials.
“It has now become my drug of choice for new-onset patients as well as for those patients who aren’t responding favorably to standard therapy,” he said.
Collapse
Healio Interviews
Read more about
Click Here to Manage Email Alerts